Product Quality and Purity Issues : Unregulated products may contain contaminants, incorrect dosages, or inconsistent formulations due to a lack of standardized manufacturing controls
Consequently, it is essential to prioritize shared decision-making and individualized risk-benefit assessments for prescribing GLP-1 RAs, while avoiding misuse with off-label indications
The IV is inserted into a vein
Medical practitioners can rely on us for quality products, fast deliveries, and superior service
We see absolutely no short-term impact on our results. Moreover, even using the most optimistic forecast, we believe the impact will be very modest to our volumes in our categories, speculated Van de Put, who has nevertheless dedicated a special work stream to stay close to the issue
BMI thresholds, failed diet/behavioral programs) before allowing GLP-1 drugs ( [4] )